915720-57-9

Usage

Uses

Used in Organic Chemistry:
1-(5-fluoropyridin-2-yl)ethanamine is used as a reagent in the synthesis of various pharmaceuticals and agrochemicals, leveraging its unique chemical structure to facilitate the creation of a wide range of compounds.
Used in Pharmaceutical Development:
In the field of pharmaceuticals, 1-(5-fluoropyridin-2-yl)ethanamine is explored as a potential therapeutic agent for the treatment of medical conditions such as depression, anxiety, and attention deficit hyperactivity disorder. Its application is based on the compound's ability to interact with biological systems, although ongoing research is required to determine its precise mechanism of action and potential side effects.
Used in Agrochemical Synthesis:
Similarly, in agrochemicals, 1-(5-fluoropyridin-2-yl)ethanamine serves as a reagent in the development of compounds designed to protect crops and enhance agricultural productivity, capitalizing on its chemical properties to synthesize effective and targeted agrochemicals.

Upstream product

• 915720-56-8 2-(1-azidoethyl)-5-fluoropyridine 
• 905587-18-0 N-(1-(5-fluoropyridin-2-yl)vinyl)acetamide 
• 905587-17-9 N-(1-(5-fluoropyridin-2-yl)ethyl)acetamide 
• 41404-58-4 2-bromo-5-fluoropyridine 
• 915720-55-7 1-(5-fluoropyridin-2-yl)ethanol 
• 327056-62-2 5-fluoropicolinonitrile 
• 915720-54-6 1-(5-fluoropyridin-2-yl)ethan-1-one 

Downstream Products

• 915720-58-0 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl [(1S)-1-(5-fluoropyridin-2-yl)ethyl]carbamate 
• 905587-15-7 (S)-1-(5-fluoropyridin-2-yl)-ethanamine 
• 915720-21-7 AZ23 

Relevant academic research and scientific papers

METALLOENZYME INHIBITOR COMPOUNDS

Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6.

SUBSTITUTED HETEROCYCLIC COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TRKA) INHIBITORS

The present application relates to a series of substituted pyrazolo[1,5-a]pyridine compounds, their use as tropomyosin receptor kinase (Trk) family protein kinase inhibitors, method of making and pharmaceutical compositions comprising such compounds.

2-(IMIDAZ0LYLAMIN0)-PYRIDINE DERIVATIVES AND THEIR USE AS JAK KINASE INHIBITORS

The present inv ention relates to compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein Ring A is 5- or 6-membered heteroaryl, wherein said 5- or 6-membered heteroaryl is optionally substituted on carbon with one or more R6

Morpholine type cinnamide compound

The present invention relates to a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein R1, R2, R3, and R4 are the same or different and each represent a hydrogen atom or a C1-6 alkyl group; X1 represents a C1-6 alkylene group that may be substituted; Xa represents a methoxy group or a fluorine atom; Xb represents an oxygen atom or a methylene group, provided that Xb is only an oxygen atom when Xa is a methoxy group; and Ar1 represents an aryl group, pyridinyl group, aryloxy group, or pyridinyloxy group that may have a substituent such as a halogen atom; and to use of the compound or salt as a pharmaceutical agent.

CHEMICAL COMPOUNDS

This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.